Malignant Glioma - Is a form of malignant (cancerous)
brain tumor
Definition of brain tumor: The
growth of abnormal cells in the tissues of the
brain. Brain tumors can be benign (non-cancerous) or
malignant (cancerous).
Estimated new cases and deaths from
brain and other nervous system
tumors in the United States in 2008:

New Cases: 21,810
Deaths: 13,070 Primary and Secondary Brain
Tumors
A tumor that begins in the brain is called a
primary brain tumor. In children, most brain
tumors are primary tumors. In adults, most tumors in
the brain have spread there from the lung, breast,
or other parts of the body. When this happens, the
disease is not brain cancer. The tumor in the brain
is a secondary tumor. It is named for the
organ or the tissue in which it began.
Treatment for secondary brain tumors depends on
where the cancer started and the extent of the
disease.
Malignant brain tumors contain cancer
cells:
-
Malignant brain tumors are generally more
serious and often are life threatening.
-
They are likely to grow rapidly and crowd or
invade the surrounding healthy brain tissue.
-
Very rarely, cancer cells may break away from
a malignant brain tumor and spread to other
parts of the brain, to the spinal cord, or even
to other parts of the body. The spread of cancer
is called metastasis.
-
Sometimes, a malignant tumor does not extend
into healthy tissue. The tumor may be contained
within a layer of tissue. Or the bones of the
skull or another structure in the head may
confine it. This kind of tumor is called
encapsulated.
The most common primary brain tumors are
gliomas. They begin in glial cells. There are
many types of gliomas:
-
Astrocytoma—The tumor arises
from star-shaped glial cells called
astrocytes. In adults, astrocytomas most
often arise in the cerebrum. In children, they
occur in the brain stem, the cerebrum, and the
cerebellum. A grade III astrocytoma is sometimes
called an anaplastic astrocytoma. A grade
IV astrocytoma is usually called a
glioblastoma multiforme.
-
Brain stem glioma—The
tumor occurs in the lowest part of the brain.
Brain stem gliomas most often are diagnosed in
young children and middle-aged adults.
-
Ependymoma—The tumor arises
from cells that line the ventricles or the
central canal of the spinal cord. They are most
commonly found in children and young adults.
-
Oligodendroglioma—This rare
tumor arises from cells that make the fatty
substance that covers and protects nerves. These
tumors usually occur in the cerebrum. They grow
slowly and usually do not spread into
surrounding brain tissue. They are most common
in middle-aged adults.
Symptoms
The symptoms of gliomas or brain tumors
depend on tumor size, type, and location. Symptoms
may be caused when a tumor presses on a nerve or
damages a certain area of the brain. They also may
be caused when the brain swells or fluid builds up
within the skull.
These are the most common symptoms of gliomas or
brain tumors:
-
Headaches (usually worse in the morning)
-
Nausea or vomiting
-
Changes in speech, vision, or hearing
-
Problems balancing or walking
-
Changes in mood, personality, or ability to
concentrate
-
Problems with memory
-
Muscle jerking or twitching (seizures
or convulsions)
-
Numbness or tingling in the arms or legs
These symptoms are not sure signs of a benign or
malignant glioma or brain tumor. Other conditions
also could cause these problems. Anyone with these
symptoms should see a doctor as soon as possible.
Only a doctor can diagnose and treat the problem.
Methods of
Treatment for Malignat Glioma and Other Brain Tumors
People with brain tumors have several treatment
options. Depending on the tumor type and stage, patients may be treated
with surgery, radiation therapy, or
chemotherapy. Some patients receive a
combination of treatments.
In addition, at any stage of disease, patients
may have treatment to control pain and other
symptoms of the cancer, to relieve the side effects
of therapy, and to ease emotional problems. This
kind of treatment is called symptom management,
supportive care, or
palliative care.
The doctor is the best person to describe the
treatment choices and discuss the expected results.
A patient may want to talk to the doctor about
taking part in a clinical trial, which is a research
study of new treatment methods.
Surgery is the usual treatment for
malignant glioma and most brain tumors. Surgery to
open the skull is called a craniotomy. It is performed under general
anesthesia. Before surgery begins, the scalp is
shaved. The surgeon then makes an incision in the
scalp and uses a special type of saw to remove a
piece of bone from the skull. After removing part or
all of the tumor, the surgeon covers the opening in
the skull with that piece of bone or with a piece of
metal or fabric. The surgeon then closes the
incision in the scalp.
Sometimes surgery is not possible.
If the tumor is in the brain stem or certain other
areas, the surgeon may not be able to remove the
tumor without damaging normal brain tissue. Patients
who cannot have surgery may receive radiation or
other treatment.
Radiation therapy (also called
radiotherapy) uses high-energy rays to kill
malignant glioma and other brain tumor cells. The
radiation may come from
x-rays,
gamma rays, or
protons. A large
machine aims radiation at the tumor and the tissue
close to it. Sometimes the radiation may be directed
to the entire brain or to the spinal cord.
Radiation therapy usually follows surgery. The
radiation kills tumor cells that may remain in the
area. Sometimes, patients who cannot have surgery
have radiation therapy instead.
The patient goes to a hospital or clinic for
radiation therapy. The treatment schedule depends on
the type and size of the tumor and the age of the
patient. Each treatment lasts only a few minutes.
Doctors take steps to protect the healthy tissue
around the brain tumor:
-
Fractionation—Radiation therapy
usually is given five days a week for several
weeks. Giving the total dose of radiation over
an extended period helps to protect healthy
tissue in the area of the tumor.
-
Hyperfractionation—The patient
gets smaller doses of radiation two or three
times a day instead of a larger amount once a
day.
-
Stereotactic radiation therapy—Narrow
beams of radiation are directed at the glioma or
brain tumor from different angles. For this
procedure, the patient wears a rigid head frame.
An MRI or CT scan creates pictures of the
tumor's exact location. The doctor uses a
computer to decide on the dose of radiation
needed, as well as the sizes and angles of the
radiation beams. The therapy may be given during
a single visit or over several visits.
-
3-dimensional conformal radiation
therapy—A computer creates a
3-dimensional image of the brain tumor and
nearby brain tissue. The doctor aims multiple
radiation beams to the exact shape of the brain
tumor. The precise focus of the radiation beams
protects normal brain tissue.
-
Proton beam radiation therapy—The
source of radiation is protons rather than
x-rays. The doctor aims the proton beams
at the glioma or brain tumor. Protons can pass
through healthy tissue without damaging it.
Chemotherapy, the use of drugs to kill
cancer cells, is sometimes used to treat gliomas or
brain tumors. The drugs may be given by mouth or by
injection. Either way, the drugs enter the
bloodstream and travel throughout the body. The
drugs are usually given in cycles so that a recovery
period follows each treatment period.
Chemotherapy may be given in an outpatient part
of the hospital, at the doctor's office, or at home.
Rarely, the patient may need to stay in the
hospital.
Children are more likely than adults to have
chemotherapy. However, adults may have chemotherapy
after surgery and radiation therapy.
For some patients with recurrent cancer of
the brain, the surgeon removes the glioma or brain
tumor and implants several wafers that contain
chemotherapy. Each wafer is about the size of a
dime. Over several weeks, the wafers dissolve,
releasing the drug into the brain. The drug kills
cancer cells.
Malignant gliomas are the most common primary
brain tumor
Malignant gliomas
account for more than half of the more than 18,000
primary malignant brain tumors diagnosed each year in
the United States. These tumors are the second-most
common cause of cancer death in the 15 to 44 age group.
The outlook for patients with malignant gliomas is
poor. Median survival for
patients with moderately severe (grade III) malignant
gliomas is three to five years. For patients with the
most severe, aggressive form of malignant glioma (grade
IV glioma or glioblastoma multiforme), median survival
is less than a year.
Surgery is recommended for all operable brain tumors
and is usually followed by radiation therapy. Several
studies have shown that adding chemotherapy to radiation
can improve patients' survival. In June 2004, after the
completion of the current study, researchers announced
that adding the drug temozolomide (Temodar®) to
radiation therapy increased median survival in patients
with glioblastoma multiforme by about two months. This
approach is now considered the standard of care for the
initial treatment of these tumors.
The Glioma Outcomes Project is a study that tracked
how patients with grade III or IV malignant gliomas were
treated and what the outcomes of that treatment were. A
total of 565 patients with newly diagnosed malignant
gliomas were enrolled in the study between 1997 and
2000; 74 percent of these patients had grade IV gliomas.
Patients were treated both at academic medical
centers and by community
oncologists. Information about their care and its
outcomes was collected when patients enrolled,
immediately after they had surgery, and at three-month
intervals thereafter for two years or until the
patient's death, whichever occurred sooner.
The study's lead author is Susan M. Chang, M.D., of
the University of California, San Francisco.
The treatment patients received conformed with
practice guidelines in some respects and departed from
them in others. For example, most patients underwent
contrast-enhanced magnetic
resonance imaging (MRI) at diagnosis. This
imaging test is almost universally accepted as the test
of choice for diagnosing malignant glioma.
Also in keeping with practice guidelines, most
patients had surgery to remove as much of the tumor as
possible, followed by postoperative radiation therapy.
However, only 54 percent received chemotherapy, despite
the fact that chemotherapy has been shown to improve
survival.
Other aspects of patients' care conflicted with best
practice recommendations. For example, the American
Academy of Neurology (AAN) recommends treating glioma
patients with anti-epileptic medications only if they
have seizures as a symptom when their tumor is
diagnosed. Because these drugs can have severe side
effects, the AAN advises against prescribing them
routinely to all patients with newly diagnosed malignant
gliomas. Nevertheless, nearly 90 percent of patients in
this study received anti-epileptic medications, although
only 32 percent had seizures.
Several areas of patients' care reflected a lack of
agreement on best practice. For example, studies of the
safety and effectiveness of giving low-dose
anticoagulants to prevent
post-surgical blood clotting in glioma patients have
produced conflicting findings. In this study, only 7
percent of patients received preventive anticoagulants,
although as many as 60 percent developed blood clots
within six weeks of surgery.
Thirteen percent of newly diagnosed patients reported
symptoms of depression. However, only 28.6 percent of
these patients received antidepressant medications.
Patients' doctors may have been concerned about the
possible side effects of giving antidepressants to
patients who were also taking anti-epileptic
medications, the study authors say. The likelihood of
such adverse effects is not known.
Almost all patients received corticosteroid
medications to reduce neurologic symptoms, although
these medications may cause significant adverse effects
such as diabetes, high blood pressure, muscle pain, and
increased susceptibility to infections.
You can find more information on Malignant gliomas
and brain tumors in general at
www.cancer.gov/cancertopics/wyntk/brain/page1
Articles and Information About Health |